Reviva Pharmaceuticals Holdings, Inc.
RVPH • NASDAQ
Reviva Pharmaceuticals Holdings, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Laxminarayan Bhat, with a market cap of $9.4M.
CEOLaxminarayan Bhat
Next Earnings
Upcoming earnings announcement for Reviva Pharmaceuticals Holdings, Inc.
Date
Thursday, May 14, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.86
Earnings History
Past 12 earnings reports for Reviva Pharmaceuticals Holdings, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 30, 2026 | Q4 2025 | -$0.57Est: -$1.04 | +45.5% | - | — |  10-K |
| Nov 13, 2025 | Q3 2025 | -$0.06Est: -$0.10 | +40.0% | - | — | 10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.12Est: -$0.13 | +7.7% | - | — | 10-Q |
| May 15, 2025 | Q1 2025 | -$0.13Est: -$0.19 | +31.6% | - | — | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$0.15Est: -$0.21 | +28.6% | - | — | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.25Est: -$0.25 | 0.0% | - | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.26Est: -$0.29 | +10.3% | - | — | 10-Q |
| May 14, 2024 | Q1 2024 | -$0.25Est: -$0.42 | +40.5% | - | — | 10-Q |
| Apr 15, 2024 | Q4 2023 | -$0.35Est: -$0.32 | -9.4% | - | — | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.44Est: -$0.37 | -18.9% | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$0.55Est: -$0.28 | -96.4% | - | — | 10-Q |
| May 15, 2023 | Q1 2023 | -$0.30Est: -$0.32 | +6.3% | - | — | — |